Abstract:Background Honokiol (HNK), a natural phenolic compound derived from Magnolia plants, exhibits therapeutic effects on various diseases, including cancer. The advent of immune checkpoint inhibitors (ICIs) has marked a breakthrough in non-small cell lung cancer (NSCLC) treatment. However, a significant subset of patients exhibits primary or acquired resistance to anti-PD-1/PD-L1 therapies, necessitating the development of novel combination strategies to enhance therapeutic efficacy and overcome resistance. Purpose This study aimed to explore the anti-tumor efficacy of liposomal honokiol (Lipo-HNK) and elucidate the synergistic effects of Lipo-HNK and ICIs on NSCLC. Methods The effects of Lipo-HNK on cell proliferation and apoptosis were assessed in human lung cancer cell lines H460 and A549, and mouse Lewis lung cancer cell line (LL2). A murine lung cancer model was established by injecting LL2 cells via the tail vein to evaluate the therapeutic effects of Lipo-HNK and ICIs. Tumor microenvironment features were characterized using immunofluorescence and flow cytometry. Primary macrophages were extracted from mouse bone marrow for mechanistic studies. High-throughput sequencing and bioinformatics analyses of Lipo-HNK-treated macrophages were conducted to identify key signaling pathways, which were subsequently confirmed by Western blotting and inhibitor blockade. Results Lipo-HNK, with enhanced solubility and bioavailability, demonstrated potent cytotoxicity against NSCLC cell lines. In the murine lung cancer model, Lipo-HNK exhibited synergistic anti-cancer effects when combined with anti-PD-1 therapy. Immunofluorescence and flow cytometry analyses revealed that Lipo-HNK significantly reduced the infiltration of myeloid-derived suppressor cells (MDSCs) and M2 macrophages (CD206+). Macrophage depletion experiment showed the anti-tumor effects of Lipo-HNK was macrophage-dependent. M2 macrophages induced by tumor-conditioned medium (TCM) or interleukin-4 (IL-4) released immunosuppressive cytokines such as IL-10, Arg-1, and TGF-β. RNA sequencing analyses showed that Lipo-HNK effectively inhibited the PI3K/Akt signaling pathway, blocking macrophage polarization to the M2 type. Furthermore, the combination of Lipo-HNK and anti-PD-1 therapy led to increased CD8+ T-cell infiltration and activation, enhancing the overall anti-tumor immune response. Conclusion This study validated the anti-tumor efficacy of Lipo-HNK against NSCLC. Lipo-HNK reduced the infiltration of MDSCs and M2 macrophages by inhibiting the PI3K/Akt pathway and enhanced the therapeutic effects of ICIs. These findings provide evidence and new insights into Lipo-HNK as a promising anti-cancer drug for NSCLC treatment, highlighting its potential to overcome resistance to current ICI therapies.

Immunomodulatory and Antitumour Bioactive Labdane Diterpenoids from Leonurus Japonicus.

A new labdane-type diterpenoid from Leonurus japonicus

Anti-inflammatory Labdane Diterpenoids from the Aerial Parts of Leonurus Japonicus.

Leonurusoleanolides E-J, Minor Spirocyclic Triterpenoids from Leonurus Japonicus Fruits.

Anti-inflammatory Labdane Diterpenoids from Leonurus Macranthus.

Labdane and ent -halimane diterpenoids with STAT3-inhibitory activity from Leonurus sibiricus

Antitumor and Apoptosis Induction Effects of Lupeol on U14 Cervical Carcinoma Bearing Mice

Immunomodulatory Activity of 3 Beta,6 Beta-Dihydroxyolean-12-En-27-Oic Acid in Tumor-Bearing Mice

New di-spirocyclic labdane diterpenoids from the aerial parts of Leonurus japonicus

New lignans from the fruits of Leonurus japonicus and their hepatoprotective activities

Anti-Inflammatory Activity of Labdane and Norlabdane Diterpenoids from Leonurus sibiricus Related to Modulation of MAPKs Signaling Pathway

Bioactive constituents from the leaves of Lonicera japonica

Pimarane, abietane, and labdane diterpenoids from Euphorbia pekinensis Rupr. and their anti-tumor activities

Four Labdane Diterpenoids from Leonurus japonicus

Diterpenoids from the Aerial Parts of Leonurus Macranthus

Rec . Nat . Prod . X : X ( 2019 ) XXXX Two New Lignans from Lycopodium japonicum Thunb

Identification of Nagilactone E As a Protein Synthesis Inhibitor with Anticancer Activity

Anti-tumor Effect of Tenacissoside H and Influence on Immune Function of Lewis Lung Cancer Mice

Isovaleryl Sucrose Esters from Atractylodes japonica and Their Cytotoxic Activity

Liposomal Honokiol Inhibits Non-Small Cell Lung Cancer Progression and Enhances PD-1 Blockade Via Suppressing M2 Macrophages Polarization

Cytotoxic Terpenes from the Flowers of Inula Japonica Against Human Hepatocarcinoma Cells.